“People’s lives are now able to be lived like everyone else - except they take a few tablets,” Amelia said. “The main thing people have taken from this is hope”. Sadly Amelia is unable to start taking ...

Merck MRK announced that the FDA has accepted its supplemental new drug application (sNDA) seeking approval of its oral HIF-2α inhibitor, Welireg (belzutifan), for a new indication. The sNDA is ...

Welireg's sNDA for advanced PPGL treatment is under FDA priority review, potentially becoming the first U.S. therapy for this condition. The LITESPARK-015 trial supports the sNDA with ORR and DOR data ...

Acceptance based on objective response rate data from the Phase 2 LITESPARK-015 trial evaluating WELIREG in certain patients with advanced PPGL If approved, WELIREG would be the only available therapy ...

Merck, known as MSD outside of the United States and Canada, announced the US Food and Drug Administration (FDA) has accepted for priority review a supplemental new drug application (sNDA) seeking ...

It’s rare that technology circles back to old-school tools, but here we are using styluses to jot down notes on tablets. Of course, today’s versions swap ink and paper for pixels and precision. If you ...

The best tablets of 2024 were the new iPad Pro M4 family, Apple's sleek and thin new iPad Pro models. Will 2025 be the year that Android tablets close the gap on Apple's premium tabs? We don't ...

Patients in England and Wales with a rare genetic disorder will soon be able to access treatment with MSD's Welireg via the NHS, nearly a year after their counterparts in Scotland. In final draft ...